Noninvasive assessment of atherosclerotic plaque progression in ApoE -/- mice using susceptibility gradient mapping

Circulation: Cardiovascular Imaging

Volumn 4, Issue 3, 2011, Pages 295-303

  Makowski, Marcus R ^a,e   Varma, Gopal ^a   Wiethoff, Andrea J ^a   Smith, Alberto ^c,e,f   Mattock, Katherine ^c,e,f   Jansen, Christian H P ^a   Warley, Alice ^d,e,g   Taupitz, Matthias ^f   Schaeffter, Tobias ^a,b,c   Botnar, Rene M ^a,b,c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c BHF Centre of Excellence   (United Kingdom)

^d NIHR Biomedical Research Centre   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f PHILIPS HEALTHCARE   (United States)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atherosclerosis; Iron oxide; Molecular imaging; MRI; Plaque

Indexed keywords

APOLIPOPROTEIN E; IRON OXIDE; PRAVASTATIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; FERRIC OXIDE; GALECTIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; DRUG UPTAKE; HISTOLOGY; LIPID DIET; MALE; MASS SPECTROMETRY; MOLECULAR IMAGING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SUSCEPTIBILITY GRADIENT MAPPING; ANIMAL; BRACHIOCEPHALIC TRUNK; GENETICS; IMAGE PROCESSING; MACROPHAGE; MOUSE MUTANT; PATHOLOGY; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRACHIOCEPHALIC TRUNK; CONTRAST MEDIA; DISEASE PROGRESSION; FERRIC COMPOUNDS; GALECTIN 3; IMAGE PROCESSING, COMPUTER-ASSISTED; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC;

EID: 80051720514     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.110.957209     Document Type: Article

References (24)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:6169-6171.
2. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874. (Pubitemid 36019640)
3. Botnar RM, Buecker A, Wiethoff AJ, Parsons EC Jr, Katoh M, Katsimaglis G, Weisskoff RM, Lauffer RB, Graham PB, Gunther RW, Manning WJ, Spuentrup E. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation. 2004;110:1463-1466. (Pubitemid 39238024)
4. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103: 415-422. (Pubitemid 32105982)
5. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study. Radiology. 2003;228:777-788. (Pubitemid 37025489)
6. Taupitz M, Wagner S, Schnorr J, Kravec I, Pilgrimm H, Bergmann-Fritsch H, Hamm B. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol. 2004;39:394-405. (Pubitemid 38802814)
7. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med. 2005;54:718-724. (Pubitemid 41233769)
8. Kooi ME, Cappendijk VC, Cleutjens KBJM, Kessels AGH, Kitslaar PJEHM, Borgers M, Frederik PM, Daemen MJAP, van Engelshoven JMA. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453-2458. (Pubitemid 36605228)
9. Korosoglou G, Weiss RG, Kedziorek DA, Walczak P, Gilson WD, Schar M, Sosnovik DE, Kraitchman DL, Boston RC, Bulte JW, Weissleder R, Stuber M. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using quot;positive contrastquot; magnetic resonance imaging. J Am Coll Cardiol. 2008;52:483-491. (Pubitemid 352043838)
10. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA. Gradient echo acquisition for superparamagnetic particles with positive contrast (grasp): Sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med. 2006;55:126-135. (Pubitemid 43062936)
11. Bakker CJG, Seppenwoolde J-H, Vincken KL. Dephased MRI. Magn Reson Med. 2006;55:92-97.
12. Seppenwoolde J-H, Viergever MA, Bakker CJG. Passive tracking exploiting local signal conservation: The white marker phenomenon. Magn Reson Med. 2003;50:784-790. (Pubitemid 37187844)
13. Stuber M, Gilson WD, Schar M, Kedziorek DA, Hofmann LV, Shah S, Vonken E-J, Bulte JWM, Kraitchman DL. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with on-resonant water suppression (iron). Magn Reson Med. 2007;58:1072-1077. (Pubitemid 350074377)
14. Dahnke H, Liu W, Herzka D, Frank JA, Schaeffter T. Susceptibility gradient mapping (SGM): A new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn Reson Med. 2008;60:595-603.
15. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging. 1997;7:266-279. (Pubitemid 28356957)
16. Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, George S, Jackson C. Plaque rupture after short periods of fat feeding in the apolipoprotein e-knockout mouse: Model characterization and effects of pravastatin treatment. Circulation. 2005;111:1422-1430. (Pubitemid 40396809)
17. Wagner S, Schnorr J, Pilgrimm H, Hamm B, Taupitz M. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: Preclinical in vivo characterization. Invest Radiol. 2002;37:167-177. (Pubitemid 34259726)
18. Chen NK, Oshio K, Panych LP. Application of k-space energy spectrum analysis to susceptibility field mapping and distortion correction in gradient-echo epi. Neuroimage. 2006;31:609-622. (Pubitemid 43776658)
19. Farrar CT, Dai G, Novikov M, Rosenzweig A, Weissleder R, Rosen BR, Sosnovik DE. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed. 2008;21:453-463. (Pubitemid 351895433)
20. Liu W, Dahnke H, Jordan EK, Schaeffter T, Frank JA. In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles. NMR Biomed. 2008;21:242-250. (Pubitemid 351513672)
21. Dahnke H, Schaeffter T. Limits of detection of SPIO at 3.0 T using T2* relaxometry. Magn Reson Med. 2005;53:1202-1206. (Pubitemid 40627800)
22. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation. 2003;107:1545-1549. (Pubitemid 36378495)
23. Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC, Boyce R, Willette RN, Jucker BM. P38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol. 2008; 28:265-271. (Pubitemid 351161198)
24. Altaf N, MacSweeney ST, Gladman J, Auer DP. Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with high-grade carotid stenosis. Stroke. 2007;38:1633-1635. (Pubitemid 46684185)